NWEH’s Post

Decentralized clinical trials are taking the healthcare industry by storm, but pharmaceutical companies should bear in mind that this model may not always be the most effective.     How do you determine which strategies are optimal for ensuring research is both insightful and manageable for participants?    Talk to patients!      As Executive Director of Decentralized Clinical Trials at Worldwide Clinical Trials, Scott Palmese says, “Understand when patients will welcome decentralized tactics, and when they will not. If you don’t know the community, perhaps you should not be blanketing tactics that may not make sense and could drive patients away.”    Learn more about the role of decentralized trials below: https://lnkd.in/eZMHXbiK #patientvoices #patientcentric #clinicaltrials 

🎯 Johnson & Johnson’s Commitment to Diversity in Clinical Trials 🌍 At The Janssen Pharmaceutical Companies of Johnson & Johnson, the pharmaceutical arm of Johnson & Johnson, inclusive clinical trials are not just a goal—they’re a mission. Their focus on embedding diversity into the clinical trial process is an industry-leading approach that could significantly improve health outcomes across underrepresented communities. In our recent coverage at #DPHARM, we explore how the team at Janssen, including senior leaders like Afia Afzal, is working to bring diverse populations into the fold and ensure trials truly reflect the real-world patient landscape. With innovative programs, partnerships, and technologies, Janssen is setting a benchmark in promoting inclusivity—driving change that benefits all patients, regardless of background. 📊💡 Read more on how Johnson & Johnson is taking diversity to new heights in clinical research. #ClinicalTrials #DiversityInTrials #Janssen #JohnsonAndJohnson #HealthEquity #ClinicalResearch #Innovation #PatientCentricity Allyson Adams

In clinical trials certain metrics, such pain symptoms, are better recorded as near to real-time as feasible, while others may be efficiently gathered during site visits. This is where patient-reported outcomes (PROs) come in. Read More: https://lnkd.in/dr9-SviG #ePRO #clinicalsupply #ClinicalTrials #Clinicalresearch #ClinicalStudy #PharmaceuticalIndustry #PharmaTech #Pharma #Pharmaceutical #Healthcare #HealthcareIndustry #HealthcareSector #HealthcareInnovation #Blog #Blogs #Octalsoft

Clinical trials should be planned and carried out in a way that takes the patient's perspective into account at every level of the investigation. Read on as we explore the concept of patient-centricity in modern clinical trials. Read More: https://lnkd.in/dAqytcqY #Octalsoft #patientcentricityinclinicaltrials #challengesofsitecentricity #ClinicalTrial #EclinicalSoftware #PharmaceuticalIndustry #PharmaTech #Pharma #Pharmaceutical #CRO #Healthcare #HealthcareIndustry #HealthcareSector #HealthcareInnovation #Blog #Blogs

🔑 Tips to Strengthen Clinical Trials by Improving the Patient Experience by pharmaphorum. 💡 Clinical trials designed without patient input risk missing the mark. A patient-centric approach not only improves trust in the pharmaceutical industry but also boosts enrolment, engagement and retention—accelerating access to better medicines. Here’s how sponsors can economically integrate patient experiences into trial designs: - Simplify: Streamline processes and use plain, accessible language to connect with participants. - Offer Options: Design flexible protocols that accommodate diverse patient needs, like virtual visits or support for transportation. Tools to Use: Leverage resources like TransCelerate’s Clinical Trial Registration Tool for patient-friendly descriptions and the Study Participant Feedback Questionnaire (SPFQ) to gather real-time feedback during the trial. 🌟 Options that fit patients’ lives lead to better participation and stronger research outcomes. Read more about it: https://lnkd.in/dc8-rXpx #PatientCentricity #ClinicalTrials #HealthcareInnovation #PatientExperience

In the pharmaceutical development's evolving landscape, medical affairs have never been more critical, especially with complex therapies needing complex clinical trials. By integrating robust data analytics and regulatory expertise, medical affairs professionals are best equipped to address the complexities of clinical trials, ensuring compliance and the integration of valuable patient insights from the outset. Integrating medical affairs from early development stages is crucial, as it optimizes trial design and patient recruitment while ensuring that trials reflect patient needs and real-world conditions more. Medical affairs' early involvement is essential to reshaping the drug development process, increasing efficiency and patient outcomes. https://lnkd.in/evQscsBi

The pharmaceutical industry is undergoing a significant transformation as the demand for complex therapies continues to grow. These therapies require intricately designed clinical trials, with the integration of robust data analytics and regulatory expertise from the early stages of development becoming essential. Early involvement of medical affairs professionals ensures that clinical trials are not only compliant but also optimized for patient recruitment and reflective of real-world conditions. This shift is reshaping the drug development landscape. By prioritizing early-stage integration, the industry is driving greater efficiency in trial design, enhancing patient recruitment strategies, and ultimately improving patient outcomes. These advancements underscore the importance of adapting to new methodologies and leveraging specialized expertise to navigate the complexities of modern clinical trials.

It's fascinating to witness the pharmaceutical industry's shift towards more complex therapies and the crucial role that early integration of medical affairs plays in this transformation. By embedding robust data analytics and regulatory expertise right from the outset, we're not only enhancing compliance but also refining clinical trials for better patient recruitment and real-world applicability. This proactive approach is vital for streamlining drug development and optimizing outcomes, marking a significant evolution in bringing therapies to those needing them.

Best practices for Sponsors and CROs to master clinical site engagement. 🏥 Learn how to establish strong relationships with investigators, foster effective communication channels, and provide ongoing support and training. Understand the importance of leveraging technology solutions. https://hubs.li/Q02wP17F0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #SiteManagement #Sponsors #CROs #Salesforce

Best practices for Sponsors and CROs to master clinical site engagement. 🏥 Learn how to establish strong relationships with investigators, foster effective communication channels, and provide ongoing support and training. Understand the importance of leveraging technology solutions. https://hubs.li/Q02wP1L60 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #SiteManagement #Sponsors #CROs #Salesforce